|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade and other receivables, net of allowance for credit losses of $62 million and $76 million, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation of $908 million and $897 million, respectively | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net (note 6) | ||||||||||||||||||||
| Tradenames | ||||||||||||||||||||
| Intangible assets subject to amortization, net (note 4) | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Television Distribution Rights, Net | ||||||||||||||||||||
| Note receivable - related party (note 1) | ||||||||||||||||||||
| QVC Group | ||||||||||||||||||||
| Qurate | ||||||||||||||||||||
| Total note receivable - related party (note 1) | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Assets held for sale noncurrent (note 6) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Current debt (note 5) | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt (note 5) | ||||||||||||||||||||
| Deferred Income Tax Liabilities, Net | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Liabilities subject to compromise (note 2) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Common stock par value | ||||||||||||||||||||
| Authorized shares | ||||||||||||||||||||
| Common stock, $0.01 par value, 1 authorized share | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive earnings (loss) | ||||||||||||||||||||
| Total stockholder's equity (deficit) | ||||||||||||||||||||
| Noncontrolling interest in equity of subsidiary | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
